About Mesa Laboratories, Inc.
https://www.mesalabs.comMesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally.
CEO
Gary M. Owens
Compensation Summary
(Year 2025)
ETFs Holding This Stock
VTS.AX
Weight:0.00%
Shares:164.21K
IWM
Weight:0.02%
Shares:128.29K
XSU.TO
Weight:0.02%
Shares:128.29K
Summary
Showing Top 3 of 93
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:803.5K
Value:$69.7M
CONESTOGA CAPITAL ADVISORS, LLC
Shares:426.46K
Value:$37M
BLACKROCK, INC.
Shares:388.8K
Value:$33.73M
Summary
Showing Top 3 of 192
About Mesa Laboratories, Inc.
https://www.mesalabs.comMesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2026 | $60.74M ▲ | $32.61M ▲ | $2.48M ▼ | 4.08% ▼ | $0.45 ▼ | $10.71M ▼ |
| Q1-2026 | $59.54M ▼ | $29.43M ▼ | $4.74M ▲ | 7.96% ▲ | $0.87 ▲ | $15.17M ▲ |
| Q4-2025 | $62.13M ▼ | $36.94M ▲ | $-7.11M ▼ | -11.45% ▼ | $-1.31 ▼ | $10.48M ▲ |
| Q3-2025 | $62.84M ▲ | $33.98M ▲ | $-1.68M ▼ | -2.67% ▼ | $-0.31 ▼ | $6.12M ▼ |
| Q2-2025 | $57.83M | $31.95M | $3.43M | 5.93% | $0.63 | $12.9M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2026 | $20.42M ▼ | $430.35M ▼ | $251.88M ▼ | $178.47M ▲ |
| Q1-2026 | $21.28M ▼ | $435.74M ▲ | $263.25M ▼ | $172.5M ▲ |
| Q4-2025 | $27.32M ▼ | $433.35M ▼ | $273.52M ▼ | $159.83M ▲ |
| Q3-2025 | $30.96M ▲ | $437.15M ▼ | $281.93M ▼ | $155.21M ▼ |
| Q2-2025 | $24.34M | $454.1M | $292.65M | $161.45M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2026 | $2.48M ▼ | $8.22M ▲ | $-1.09M ▼ | $-7.88M ▲ | $-857K ▲ | $7.13M ▲ |
| Q1-2026 | $4.74M ▲ | $1.89M ▼ | $-1.01M ▼ | $-8.43M ▲ | $-6.04M ▼ | $884K ▼ |
| Q4-2025 | $-7.11M ▼ | $12.66M ▼ | $-1.01M ▼ | $-16.19M ▼ | $-3.63M ▼ | $11.66M ▼ |
| Q3-2025 | $-1.68M ▼ | $18.44M ▲ | $-813K ▲ | $-10.6M ▼ | $6.62M ▲ | $17.63M ▲ |
| Q2-2025 | $3.43M | $5.27M | $-1.79M | $-8.61M | $-4.13M | $3.48M |
Revenue by Products
| Product | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|
 Biopharmaceutical Development | $0 ▲ | $0 ▲ | $10.00M ▲ | $10.00M ▲ |
 Calibration Solutions | $0 ▲ | $0 ▲ | $10.00M ▲ | $10.00M ▲ |
 Clinical Genomics | $0 ▲ | $0 ▲ | $10.00M ▲ | $10.00M ▲ |
 Sterilization and Disinfection Control | $0 ▲ | $0 ▲ | $30.00M ▲ | $20.00M ▼ |
 Product | $60.00M ▲ | $20.00M ▼ | $0 ▼ | $0 ▲ |
Revenue by Geography
| Region | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|
 CHINA | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ |
 Other | $30.00M ▲ | $30.00M ▲ | $30.00M ▲ | $30.00M ▲ |
 UNITED STATES | $30.00M ▲ | $30.00M ▲ | $30.00M ▲ | $30.00M ▲ |
CEO
Gary M. Owens
Compensation Summary
(Year 2025)
ETFs Holding This Stock
VTS.AX
Weight:0.00%
Shares:164.21K
IWM
Weight:0.02%
Shares:128.29K
XSU.TO
Weight:0.02%
Shares:128.29K
Summary
Showing Top 3 of 93
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:803.5K
Value:$69.7M
CONESTOGA CAPITAL ADVISORS, LLC
Shares:426.46K
Value:$37M
BLACKROCK, INC.
Shares:388.8K
Value:$33.73M
Summary
Showing Top 3 of 192